MuLBSTA Score for Viral Pneumonia Mortality
Predicts 90-day mortality in patients with viral pneumonia.
Launched during COVID-19 crisis. Not externally validated. Use with caution.
Tips for COVID-19: Use after diagnosis to determine dispo. Specific for Viral PNA and similar inputs as known COVID-19 mortality risk factors, but not externally validated.
-
Threshold for disposition may change during resource-limited situations such as the current COVID-19 outbreak.
-
Take into consideration that the upper limit of the “low risk” group as indicated in the original study still carries a relatively high mortality rate (e.g. 11 points = 12.27% mortality).
If applying to a patient with potential COVID-19, use this score in conjunction with clinical suspicion and risk factors - particularly advanced age and comorbidities.